Jaque, Urica .
HRN: 27-72-90 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/05/2025
CEFUROXIME 750MG (VIAL)
09/05/2025
09/12/2025
IVT
750 Mg
Q8
Nephrotic Syndrome
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines